Effects of dexmedetomidine on inflammatory responses in patients undergoing major abdominal surgeries

Salem, Raffat; Ahmed, Islam; Abdelrahman, Abdelrahman; Diab, Zienab

doi:10.21608/smj.2017.39249

Effects of dexmedetomidine on inflammatory responses in patients undergoing major abdominal surgeries

Document Type : Original Article

Authors

Department, of Anesthesia & Intensive Care, Faculty of Medicine, Sohag University.

10.21608/smj.2017.39249

Abstract

Background: Surgical injury to tissue as in major abdominal surgeries causes a variety of profound inflammatory response which may lead to postoperative complications with significant co morbidity. Dexmedetomidine, a highly selective α2-adrenoceptor agonist, is widely used in clinical anaesthesia, and intensive care unit. The aim of this study is to evaluate the anti inflammatory effect of dexmedetomidine in major abdominal surgeries.
Patients and methods: 40 patients for radical cystectomy in the age range of 40 – 65 years participated in this prospective, randomized, double blinded, placebo controlled clinical study. Patients were randomly assigned to receive either Dexmeditomidine (Dex group) or normal saline (0.9%) (Control group). Serum tumor necrosis factor (TNF-α), Interleukin-6 (IL-6), glucose, cortisol, and C-reactive protein (CRP) were analyzed before the start of the study drug infusion, after complete recovery and the day one postoperatively.
Results: inflammatory markers were significantly higher in both groups compared to baseline measurements. TNF-α, IL-6, glucose, and cortisol measurements were less in Dex group in postoperative period.
Conclusion:Dexmedetomidine is effective in attenuating the postoperative rise of the proinflammatory cytokine interleukin-6 and tumor necrosis factor (TNF-α) and resulted in lower levels of markers of stress response to surgery as cortisol and blood glucose.

References

Aho, M, Scheinin, M, Lehtinen, A, Erkola, O. Intramuscularly administered dexmedetomidine attenuates hemodynamic and stress hormone responses to gynecologic laparoscopy. AnesthAnalg 1992, 75, 932-9.
Bekker, A, Haile, M, Kline, R, Didehvar, S, abu, R. The effect of intraoperative infusion of dexmedetomidine on the quality of recovery after major spinal surgery. J NeurosurgAnesthesiol 2013, 25, 16-24.
Clark, I. A. How TNF was recognized as a key mechanism of disease. Cytokine Growth Factor Rev. 18, 335–43 (2007).
Goldfarb Y, Sorski L, Benish M, Levi B, Melamed R, Ben-Eliyahu S. Improving postoperative immune status and resistance to cancer metastasis: a combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses. Ann Surg. 2011; 253:798–810.
Homburger JA, Meiler SE. Anesthesia drugs, immunity, and long- erm outcome. CurrOpinAnaesthesiol. 2006; 19:423–8.
Jameson, P., Desborough, J. P., Bryant, A. E. & Hall, G. M. The effect of cortisol suppression on IL-6 and white blood cell responses to surgery. ActaAnaesthiol Scand. 41, 304–8 (1997).
Kang, S. H. et al. Effects of dexmedetomidine on inflammatory responses in patients undergoing laparoscopic cholecystectomy. ActaAnaesthesiol Scand. 57, 480–7 (2013).
Li, YY, Ge, DJ, Li, JY, and Qi, B, Sex Differences in the Morphine-Sparing Effects of Intraoperative Dexmedetomidine in Patient-Controlled Analgesia Following General Anesthesia: A Consort-Prospective, Randomized, Controlled Clinical Trial. Medicine (Baltimore), 2016. 95(18): p. e3619.
Mukhtar,AM, Obayah, EM, Hassona, AM. Preliminary experience with dexmedetomidine in pediatricanesthesia. AnesthAnalg 2006, 103, 250.
O’Riain SC, Buggy DJ, Kerin MJ. Inhibition of the stress response to breast cancer surgery by regional anesthesia and analgesia does not affect vascular endothelial growth factor and prostaglandin E2. AnesthAnalg 2005;100:1244–9.
Sheeran, P. & Hall, G. M. Cytokines in anesthesia. BJA. 78, 201–19 (1997).
Tasdogan M, Memis D, Sut N, Yuksel M. Results of a pilot study on the effects of propofol and dexmedetomidine on inflammatory responses and intraabdominal pressure in severe sepsis. J ClinAnesth. 2009; 21:394–400.
Ueki, M, Kawasaka, T, Haba, K., Hamada, K., Kawazaki, C. The effects of dexmedetomidine on inflammatory mediators after cardiopulmonary bypass. Anaesthesia 2014, 69, 693-700.
Velickovic I, Yan J, Gross JA. Modifying the neuroendocrine stress response. Seminars in anaesthesia. Perioper Med Pain 2002;21:16–25.
Westaby S, Saatvedt K, White S, Katsumata T, van Oeveren W, Halligan PW. Is there a relationship between cognitive dysfunction and systemic inflammatory response after cardiopulmonary bypass?AnnThorac Surg. 2001; 71:667–72.
Xianbao, L.; Hong, Z.; Xu, Z.; Chunfang, Z.; Dunjin, C. Dexmedetomidine reduced cytokine release during postpartum bleeding-induced multiple organ dysfunction syndrome in rats. Mediat. Inflamm. 2013, 2013, 627831.
Yacout, A., Osman, H, Abdeldaem, M, Hammouda, S. Effect of intravenous dexmedetomidine infusion on some proinflammatory cytokines, stress hormones and recovery profile in major abdominal surgery. Alexandria Journal of Medicine 2012, 48, 3-8.